申请人:Almirall, S.A.
公开号:EP2548876A1
公开(公告)日:2013-01-23
The present invention relates to compounds of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by CRTh2 antagonist activity.
本发明涉及式(I)的化合物,制备这种化合物的方法以及它们在治疗病理状况或疾病中的应用,该病理状况或疾病容易通过CRTh2拮抗活性得到改善。